GB0301608D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0301608D0
GB0301608D0 GB0301608A GB0301608A GB0301608D0 GB 0301608 D0 GB0301608 D0 GB 0301608D0 GB 0301608 A GB0301608 A GB 0301608A GB 0301608 A GB0301608 A GB 0301608A GB 0301608 D0 GB0301608 D0 GB 0301608D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0301608A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0301608A priority Critical patent/GB0301608D0/en
Publication of GB0301608D0 publication Critical patent/GB0301608D0/en
Priority to TW092106766A priority patent/TW200400035A/en
Priority to CNA038115506A priority patent/CN1656092A/en
Priority to PT03745294T priority patent/PT1487828E/en
Priority to BR0308780-8A priority patent/BR0308780A/en
Priority to DK03745294T priority patent/DK1487828T3/en
Priority to JP2003580326A priority patent/JP4465195B2/en
Priority to US10/509,162 priority patent/US7622464B2/en
Priority to KR10-2004-7015398A priority patent/KR20040093488A/en
Priority to AT03745294T priority patent/ATE413399T1/en
Priority to ES03745294T priority patent/ES2315519T3/en
Priority to RU2004127928/04A priority patent/RU2004127928A/en
Priority to DE60324535T priority patent/DE60324535D1/en
Priority to CA002480106A priority patent/CA2480106A1/en
Priority to MXPA04009459A priority patent/MXPA04009459A/en
Priority to PCT/EP2003/003335 priority patent/WO2003082861A2/en
Priority to AU2003226757A priority patent/AU2003226757A1/en
Priority to IL16404703A priority patent/IL164047A0/en
Priority to AR20030101081A priority patent/AR040403A1/en
Priority to SI200331471T priority patent/SI1487828T1/en
Priority to EP03745294A priority patent/EP1487828B1/en
Priority to IS7444A priority patent/IS7444A/en
Priority to NO20044448A priority patent/NO20044448L/en
Priority to CY20081101474T priority patent/CY1108652T1/en
Ceased legal-status Critical Current

Links

GB0301608A 2002-03-28 2003-01-24 Novel compounds Ceased GB0301608D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GB0301608A GB0301608D0 (en) 2003-01-24 2003-01-24 Novel compounds
TW092106766A TW200400035A (en) 2002-03-28 2003-03-26 Novel compounds
EP03745294A EP1487828B1 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
ES03745294T ES2315519T3 (en) 2002-03-28 2003-03-27 MORFOLINILUREA DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES.
CA002480106A CA2480106A1 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
BR0308780-8A BR0308780A (en) 2002-03-28 2003-03-27 Compound, process for the preparation and use thereof, method for treating a human or animal subject suffering from, or susceptible to, an inflammatory condition, and, pharmaceutical composition.
DK03745294T DK1487828T3 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
JP2003580326A JP4465195B2 (en) 2002-03-28 2003-03-27 New compounds
US10/509,162 US7622464B2 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
KR10-2004-7015398A KR20040093488A (en) 2002-03-28 2003-03-27 Novel compounds
AT03745294T ATE413399T1 (en) 2002-03-28 2003-03-27 MORPHOLINYL UREA DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATORY PROCESSES
CNA038115506A CN1656092A (en) 2002-03-28 2003-03-27 Robertson Graeme Michael et al.
RU2004127928/04A RU2004127928A (en) 2002-03-28 2003-03-27 MORPHOLINYL UREA DERIVATIVES FOR USE IN TREATMENT OF INFLAMMATORY DISEASES
DE60324535T DE60324535D1 (en) 2002-03-28 2003-03-27 MORPHOLINYL UREA DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEFENSIVE PROCESSES
PT03745294T PT1487828E (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
MXPA04009459A MXPA04009459A (en) 2002-03-28 2003-03-27 Novel compounds.
PCT/EP2003/003335 WO2003082861A2 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
AU2003226757A AU2003226757A1 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
IL16404703A IL164047A0 (en) 2002-03-28 2003-03-27 Novel compounds
AR20030101081A AR040403A1 (en) 2002-03-28 2003-03-27 CCR3 ANTAGONIST MORPHOLINE DERIVATIVES
SI200331471T SI1487828T1 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
IS7444A IS7444A (en) 2002-03-28 2004-09-13 Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
NO20044448A NO20044448L (en) 2002-03-28 2004-10-19 New connections
CY20081101474T CY1108652T1 (en) 2002-03-28 2008-12-19 MORPHOLINYL-URINE PRODUCTS FOR USE IN THE INFECTION OF INFECTIOUS DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0301608A GB0301608D0 (en) 2003-01-24 2003-01-24 Novel compounds

Publications (1)

Publication Number Publication Date
GB0301608D0 true GB0301608D0 (en) 2003-02-26

Family

ID=9951702

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0301608A Ceased GB0301608D0 (en) 2002-03-28 2003-01-24 Novel compounds

Country Status (1)

Country Link
GB (1) GB0301608D0 (en)

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
GB0308186D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
EP1596860A4 (en) Novel compounds
EP1648885A4 (en) Novel compounds
GB0305426D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
EP1635834A4 (en) Novel compounds
GB0305163D0 (en) Novel compounds
GB0303464D0 (en) Novel compounds
GB0305586D0 (en) Novel compounds
GB0305564D0 (en) Novel compounds
GB0305293D0 (en) Novel compounds
GB0305292D0 (en) Novel compounds
GB0305291D0 (en) Novel compounds
GB0301480D0 (en) Novel compounds
GB0305290D0 (en) Novel compounds
GB0305285D0 (en) Novel compounds
GB0305165D0 (en) Novel compounds
GB0301608D0 (en) Novel compounds
GB0304811D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)